Stay updated with breaking news from Tatiana kisseleva. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Selective, Toxin-Bearing Antibodies Could Help Treat Liver Fibrosis scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
Selective, Toxin-Bearing Antibodies Could Help Treat Liver Fibrosis ucsd.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ucsd.edu Daily Mail and Mail on Sunday newspapers.
E-Mail IMAGE: Debanjan Dhar, PhD, is co-senior author of the study and assistant professor in the Department of Medicine, Division of Gastroenterology at UC San Diego School of Medicine. view more Credit: UC San Diego Health Sciences Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. NAFLD patients are at higher risk of developing Non-alcoholic steatohepatitis (NASH), which causes severe and chronic liver inflammation, fibrosis and liver damage. A patient with NASH is believed to be at high risk for developing a form of liver cancer called hepatocellular carcinoma (HCC). Apart from lifestyle interventions, there are currently no approved treatments for NASH. A liver transplant is sometimes the only remedy. ....